Syneos Health, Inc.
SYNH · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $5,393 | $5,213 | $4,416 | $4,676 |
| % Growth | 3.5% | 18.1% | -5.6% | – |
| Cost of Goods Sold | $4,139 | $3,994 | $3,398 | $3,646 |
| Gross Profit | $1,254 | $1,218 | $1,018 | $1,030 |
| % Margin | 23.3% | 23.4% | 23% | 22% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $547 | $571 | $442 | $446 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $247 | $236 | $222 | $242 |
| Operating Expenses | $794 | $806 | $665 | $689 |
| Operating Income | $403 | $389 | $293 | $325 |
| % Margin | 7.5% | 7.5% | 6.6% | 6.9% |
| Other Income/Exp. Net | -$89 | -$74 | -$89 | -$136 |
| Pre-Tax Income | $315 | $315 | $204 | $102 |
| Tax Expense | $48 | $80 | $11 | -$30 |
| Net Income | $266 | $235 | $193 | $131 |
| % Margin | 4.9% | 4.5% | 4.4% | 2.8% |
| EPS | 2.57 | 2.26 | 1.85 | 1.27 |
| % Growth | 13.7% | 22.2% | 45.7% | – |
| EPS Diluted | 2.54 | 2.24 | 1.83 | 1.25 |
| Weighted Avg Shares Out | 103 | 104 | 104 | 104 |
| Weighted Avg Shares Out Dil | 103 | 105 | 105 | 105 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $0 | $0 | $8 |
| Interest Expense | $81 | $79 | $91 | $130 |
| Depreciation & Amortization | $297 | $267 | $285 | $242 |
| EBITDA | $700 | $656 | $578 | $567 |
| % Margin | 13% | 12.6% | 13.1% | 12.1% |